Because previous work in rats and monkeys has found that proteins that block the costimulatory signal can hold T cells at bay, Kim Olthoff, a transplant surgeon at the University of Pennsylvania Medical Center in Philadelphia, thought her team could achieve a
targeted immune suppression by getting the transplanted
organ itself — rather
than proteins injected into the bloodstream — to block the costimulatory signal.